Summary of direct, indirect, and net evidence for the associations of tocilizumab, sarilumab and usual care or placebo with all-cause mortality 28 days after randomisation for patients receiving corticosteroids and either NIV, IMV or ECMO at randomisation.
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://figshare.com/articles/dataset/Summary_of_direct_indirect_and_net_evidence_for_the_associations_of_tocilizumab_sarilumab_and_usual_care_or_placebo_with_all-cause_mortality_28_days_after_randomisation_for_patients_receiving_corticosteroids_and_either_NIV_IMV_or_ECMO_at_ra/20275613
下载链接
链接失效反馈官方服务：
资源简介：
Summary of direct, indirect, and net evidence for the associations of tocilizumab, sarilumab and usual care or placebo with all-cause mortality 28 days after randomisation for patients receiving corticosteroids and either NIV, IMV or ECMO at randomisation.
创建时间：
2022-07-08
